Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Freeman

Showing results (811-820 of 954) with videos related to

Pageof 96
Sort By:
International Clinical Psychopharmacology|August 18, 2020
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity studyGeorge I Papakostas, Maurizio Fava, Marlene P Freeman, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 25, 2017
The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette SmokersWill Lawn, Tom P Freeman, Katie East, et al.
Translational Psychiatry|May 14, 2020
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?Chandni Hindocha, Diego Quattrone, Tom P Freeman, et al.
Depression and Anxiety|April 18, 2020
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysisMarlene P Freeman, Maurizio Fava, Bryan Dirks, et al.
Journal of Affective Disorders|September 2, 2020
Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY studyRichard C Shelton, Maurizio Fava, Marlene P Freeman, et al.
Drug and Alcohol Dependence|January 28, 2015
Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United KingdomChandni Hindocha, Natacha D C Shaban, Tom P Freeman, et al.
Drug and Alcohol Dependence|September 24, 2025
Three-day blues after ecstasy/MDMA use: Evidence from a longitudinal and daily analysis in the European nightlife sceneMatthijs Blankers, Ruben van Beek, Desirée Spronk, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Hepatology (Baltimore, Md.)|May 24, 2012
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfectionVincent Lo Re, Jessica Volk, Craig W Newcomb, et al.
Journal of Psychiatric Research|January 15, 2019
Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depressionMarlene P Freeman, George I Papakostas, Bettina Hoeppner, et al.
Pageof 96

Showing results (811-820 of 954) with videos related to

Sort By:
Pageof 96
International Clinical Psychopharmacology|August 18, 2020
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity studyGeorge I Papakostas, Maurizio Fava, Marlene P Freeman, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 25, 2017
The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette SmokersWill Lawn, Tom P Freeman, Katie East, et al.
Translational Psychiatry|May 14, 2020
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?Chandni Hindocha, Diego Quattrone, Tom P Freeman, et al.
Depression and Anxiety|April 18, 2020
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysisMarlene P Freeman, Maurizio Fava, Bryan Dirks, et al.
Journal of Affective Disorders|September 2, 2020
Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY studyRichard C Shelton, Maurizio Fava, Marlene P Freeman, et al.
Drug and Alcohol Dependence|January 28, 2015
Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United KingdomChandni Hindocha, Natacha D C Shaban, Tom P Freeman, et al.
Drug and Alcohol Dependence|September 24, 2025
Three-day blues after ecstasy/MDMA use: Evidence from a longitudinal and daily analysis in the European nightlife sceneMatthijs Blankers, Ruben van Beek, Desirée Spronk, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Hepatology (Baltimore, Md.)|May 24, 2012
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfectionVincent Lo Re, Jessica Volk, Craig W Newcomb, et al.
Journal of Psychiatric Research|January 15, 2019
Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depressionMarlene P Freeman, George I Papakostas, Bettina Hoeppner, et al.
Pageof 96